Related Experiment Video
Updated: Jul 3, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
An overview of stem cell-based clinical trials in China
Lianming Liao1, Robert Chunhua Zhao
1Institute of Basic Medical Sciences & School of Basic Medicine, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract:
Adult human stem cells are capable of maintaining, generating, and replacing terminally differentiated cells within their own specific tissue. Data suggest that adult stem cells (ASCs) generate differentiated cells beyond their own tissue boundaries, a process termed "developmental plasticity." Since early reports of developmental plasticity in animal models, researchers have made enormous advances in moving toward clinically applicable treatment options with stem cells from both bone marrow and peripheral blood. It seems China is entering this new therapeutic era more rapidly than other countries around the world. In this review, we focus on therapeutic applications of ASCs derived from bone marrow and peripheral blood. Furthermore, we also discuss concerns related to regulations monitoring stem cell-based clinical trials.
Insights
Adult stem cells (ASCs) show developmental plasticity, generating cells beyond their native tissues. This review explores therapeutic uses of bone marrow and peripheral blood ASCs, alongside regulatory considerations for clinical trials.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Biotechnology
Background:
- Adult stem cells (ASCs) possess self-renewal and differentiation capabilities within their specific tissues.
- Emerging evidence indicates ASCs exhibit "developmental plasticity," generating cells outside their original tissue lineage.
- Significant advancements have been made in utilizing ASCs for clinical applications, particularly from bone marrow and peripheral blood.
Purpose of the Study:
- To review the therapeutic applications of adult stem cells derived from bone marrow and peripheral blood.
- To discuss the phenomenon of "developmental plasticity" in adult stem cells.
- To examine regulatory concerns surrounding stem cell-based clinical trials.
Main Methods:
- Literature review focusing on adult stem cell research.
- Analysis of studies on bone marrow and peripheral blood stem cell applications.
- Examination of regulatory frameworks for stem cell therapies.
Main Results:
- Adult stem cells demonstrate potential for generating diverse cell types beyond their tissue of origin.
- Bone marrow and peripheral blood stem cells are key sources for current therapeutic strategies.
- China is noted for rapid progress in stem cell therapeutics.
Conclusions:
- Adult stem cell plasticity offers promising avenues for regenerative medicine.
- Therapeutic applications of bone marrow and peripheral blood ASCs are advancing rapidly.
- Careful consideration of regulatory oversight is crucial for safe and effective stem cell clinical trials.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Clinical Trials: Overview
Adult Stem Cells
